Facilitating Use of the National Suicide Prevention Lifeline in Alcohol Patients (Reach Out)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04488055 |
Recruitment Status :
Recruiting
First Posted : July 27, 2020
Last Update Posted : July 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Suicide Alcohol Use Disorder | Behavioral: Crisis Line Facilitation (CLF) Behavioral: Enhanced Usual Care (EUC) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 500 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Facilitating Use of the National Suicide Prevention Lifeline in Alcohol Patients |
Actual Study Start Date : | October 15, 2020 |
Estimated Primary Completion Date : | June 2024 |
Estimated Study Completion Date : | June 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: Crisis Line Facilitation (CLF)
This single-session intervention addresses the individuals' perceived barriers and facilitators of crisis line use during periods of suicidal crisis.
|
Behavioral: Crisis Line Facilitation (CLF)
CLF is a motivational interviewing-based intervention |
Active Comparator: Enhanced Usual Care (EUC)
Participants randomized to the EUC condition will receive a brochure (in-person, via email, or via text message) with the NSP Lifeline and a list of outpatient mental health and substance use resources and encouraged to schedule an appointment with a clinical provider if they would like to discuss any current or past symptoms.
|
Behavioral: Enhanced Usual Care (EUC)
In addition to receiving the brochure, EUC condition participants will meet with a therapist (in-person or remotely) for approximately 15 minutes for a descriptive overview of the brochure. |
- Crisis line utilization [ Time Frame: Up to 12 months ]The Time Line Follow Back (TLFB) assessment will be used as the primary measure of crisis line utilization. Participants will report days of utilization.
- Suicidal behavior [ Time Frame: Up to 12 months ]The Time Line Follow Back (TLFB) assessment will be the primary measure of suicidal behavior. Participants will report days with suicidal behavior.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Probable alcohol use disorder within the past year based on an Alcohol Use Disorders Identification Test (AUDIT) score of 16 or greater
- Report of a suicide attempt within the past year OR a lifetime suicide attempt more than a year ago and current suicide ideation within the past month based on a score of 5 or greater on the Beck Scale for Suicidal Ideation (BSS) or depression in the past month as measured by the Beck Depression Inventory with a of 20 or higher.
Exclusion Criteria:
- Patients who do not understand English
- Prisoners
- Patients with profound psychotic symptoms and/or cognitive deficits that would prevent patients from understanding the content of the intervention and/or assessments.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04488055
Contact: Amanda Price, MS | 734-998-6652 | amhprice@med.umich.edu |
United States, Michigan | |
Detroit Rescue Mission Ministries | Recruiting |
Detroit, Michigan, United States, 48201 | |
Contact: Amanda Price, MS 734-998-6652 amhprice@med.umich.edu | |
Meridian Health Services | Recruiting |
Waterford, Michigan, United States, 48327 | |
Contact: Amanda Price, MS 734-998-6652 amhprice@med.umich.edu |
Principal Investigator: | Mark Ilgen, PhD | University of Michigan |
Responsible Party: | Mark A. Ilgen, Professor, Department of Psychiatry, University of Michigan |
ClinicalTrials.gov Identifier: | NCT04488055 |
Other Study ID Numbers: |
HUM00164699 1R01AA027513-01 ( U.S. NIH Grant/Contract ) |
First Posted: | July 27, 2020 Key Record Dates |
Last Update Posted: | July 8, 2022 |
Last Verified: | July 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
National Suicide Prevention Lifeline |
Alcoholism Suicide Self-Injurious Behavior Behavioral Symptoms |
Alcohol-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |